Stock Earnings
Investing in Galectin Therapeutics Inc (GALT) Is Getting More Attractive
Galectin Therapeutics Inc’s recently made public that its Director ELDRED KARY acquired Company’s shares for reported $2925.0 on Jul 21
Menu
Galectin Therapeutics Inc’s recently made public that its Director ELDRED KARY acquired Company’s shares for reported $2925.0 on Jul 21
Relmada Therapeutics Inc’s recent filing unveils that its Chief Operating Officer Kelly Paul Edward acquired Company’s shares for reported $86060.0
In a filing, Olo Inc revealed its Director Washington Zuhairah Scott unloaded Company’s shares for reported $84820.0 on Jun 16
Flushing Financial Corp’s filing revealed that its Sr. EVP BUONAIUTO THOMAS unloaded Company’s shares for reported $87856.0 on Mar 12
H.B. Fuller Company’s recently made public that its VP, Corporate Controller Martsching Robert J unloaded Company’s shares for reported $0.61
F5 Inc’s recent filing unveils that its President, CEO & Director Locoh-Donou Francois unloaded Company’s shares for reported $0.38 million
In a filing, Fuel Tech Inc revealed its Director Jones Sharon L unloaded Company’s shares for reported $21043.0 on Jun
ModivCare Inc’s filing revealed that its 10% Owner AI Catalyst Fund, LP acquired Company’s shares for reported $0.76 million on
Chegg Inc’s recently made public that its Director BUDIG RENEE VARNI unloaded Company’s shares for reported $39554.0 on Jun 06
In a filing, WM Technology Inc revealed its Director Ibbott William Glen unloaded Company’s shares for reported $46040.0 on Jun